If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Holding(s) in Company

18 May 2021 09:18

RNS Number : 9809Y
Aberdeen Latin American Inc Fd Ltd
18 May 2021
 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

JE00B44ZTP62

Issuer Name

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

1607 Capital Partners, LLC

City of registered office (if applicable)

Richmond

Country of registered office (if applicable)

United States

4. Details of the shareholder

Name

City of registered office

Country of registered office

Bank of New York Mellon

New York

United States

The Northern Trust Company

Chicago

United States

5. Date on which the threshold was crossed or reached

14-May-2021

6. Date on which Issuer notified

17-May-2021

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

11.090000

0.000000

11.090000

6336280

Position of previous notification (if applicable)

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

JE00B44ZTP62

0

6336280

0.000000

11.090000

Sub Total 8.A

6336280

11.090000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

Sub Total 8.B1

 

 

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

Sub Total 8.B2

 

 

 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

The date until which the voting rights will be held

 

11. Additional Information

Bryan Huntley, CCO804-525-21741

12. Date of Completion

17-May-2021

13. Place Of Completion

Richmond, VA

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLVVLBFFELFBBX
Date   Source Headline
10th Dec 202012:48 pmRNSFirst Interim Dividend
10th Dec 202012:30 pmRNSNet Asset Value(s)
10th Dec 202010:27 amRNSResult of AGM
9th Dec 202011:06 amRNSNet Asset Value(s)
8th Dec 202011:49 amRNSNet Asset Value(s)
7th Dec 202012:10 pmRNSGearing Disclosure
7th Dec 202011:09 amRNSNet Asset Value(s)
4th Dec 20202:31 pmRNSMonth End Net Asset Value(s)
4th Dec 202011:13 amRNSNet Asset Value(s)
3rd Dec 202012:39 pmRNSNet Asset Value(s)
2nd Dec 20203:47 pmRNSQuarterly disclosure
2nd Dec 20201:16 pmRNSNet Asset Value(s)
30th Nov 20202:58 pmRNSGearing disclosure
30th Nov 202011:54 amRNSNet Asset Value(s)
27th Nov 202012:47 pmRNSNet Asset Value(s)
26th Nov 202012:22 pmRNSNet Asset Value(s)
25th Nov 202012:53 pmRNSNet Asset Value(s)
24th Nov 202012:42 pmRNSNet Asset Value(s)
23rd Nov 20201:23 pmRNSGearing disclosure
23rd Nov 202012:50 pmRNSNet Asset Value(s)
20th Nov 202011:05 amRNSNet Asset Value(s)
19th Nov 202011:04 amRNSNet Asset Value(s)
18th Nov 20201:25 pmRNSNet Asset Value(s)
18th Nov 20209:45 amRNSNet Asset Value(s)
17th Nov 20207:00 amRNSDoc re. Annual Report
16th Nov 20201:29 pmRNSGearing disclosure
16th Nov 20201:14 pmRNSNet Asset Value(s)
13th Nov 202012:24 pmRNSNet Asset Value(s)
13th Nov 202012:00 pmRNSPortfolio disclosure
12th Nov 202010:56 amRNSNet Asset Value(s)
11th Nov 202011:13 amRNSNet Asset Value(s)
10th Nov 202011:19 amRNSNet Asset Value(s)
9th Nov 20202:33 pmRNSGearing disclosure
9th Nov 202012:12 pmRNSNet Asset Value(s)
6th Nov 202011:41 amRNSNet Asset Value(s)
5th Nov 20201:59 pmRNSMonth End Net Asset Value(s)
5th Nov 202011:14 amRNSNet Asset Value(s)
5th Nov 20207:00 amRNSAnnual Financial Report
4th Nov 202012:20 pmRNSNet Asset Value(s)
3rd Nov 20202:13 pmRNSNet Asset Value(s)
3rd Nov 20209:36 amRNSHolding(s) in Company
2nd Nov 20202:38 pmRNSGearing disclosure
30th Oct 202012:44 pmRNSNet Asset Value(s)
29th Oct 202012:40 pmRNSNet Asset Value(s)
28th Oct 202012:20 pmRNSNet Asset Value(s)
27th Oct 202011:02 amRNSNet Asset Value(s)
26th Oct 20203:27 pmRNSGearing Disclosure
26th Oct 202012:30 pmRNSNet Asset Value(s)
23rd Oct 20201:44 pmRNSNet Asset Value(s)
22nd Oct 202012:56 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.